baber/WOPTO huggingface dataset:
Patent JP-3659645-B2 (JP)
IPC: F04D15/00
Filed: 1994-08-31
Granted: 2005-06-15
Abstract: An improved apparatus (30) for transporting the metering particulate material (40) including a transport duct (36) having an inlet (32), an outlet (34), and at least one moving surface (31) located therebetween having a downstream facing drive surface. The apparatus further includes drive device for moving the moving surface (31) between the inlet (32) and the outlet (34) towards the outlet, and means for compacting the particulate material sufficiently to cause the formation of a bridge composed of substantially interlocking particulate material (40) spanning the width of the transport duct (36). The apparatus is used to transport and meter particulate material under ambient conditions and against pressure.
Patent JP-4293641-B2 (JP)
IPC: C12N9/10
Filed: 1998-07-16
Granted: 2009-07-08
Abstract: Genes encoding proteins each having an amino acid sequence represented by any of SEQ ID NOS: 7 to 10 and 12 showing the activity of transferring a glycosyl group to the 5-position of a flavonoid; genes encoding protein each having an amino acid sequence derived from any of the above amino acid sequences by modification and showing the activity of transferring a glycosyl group to the 5-position of a flavonoid; and a process for producing the above proteins with the use of these genes. These genes are usable in, for example, artificially improving plant colors.
Patent JP-3590872-B2 (JP)
IPC: H01H1/00
Filed: 1997-08-26
Granted: 2004-11-17
Abstract: A thin plate-shaped substrate 21 comprised of a monocrystal is provided with a piezoelectric element 24, and both ends of a movable piece 20 whose one surface is provided with a movable contact 25 are fixed and supported to a base 11. Then, by curving the movable piece 20 via the piezoelectric element 24, the movable contact 25 is brought in and out of contact with a pair of fixed contacts 38 and 39 that face the movable contact. With this arrangement, a subminiature micro-relay having a mechanical contact mechanism that has a small resistance in turning on the contact and the desired vibration resistance, frequency characteristic and insulating property can be obtained.
Patent JP-2915146-B2 (JP)
IPC: A61P25/28
Filed: 1995-10-04
Granted: 1999-07-05
Abstract: The particle size of modafinil can have a significant effect on the potency and safety profile of the drug. The invention describes a process for the preparation of certain modafinil pharmaceutical compositions for use in altering the somnolent state of a mammal.
Patent JP-4063321-B2 (JP)
IPC: G11B7/24035
Filed: 1996-09-24
Granted: 2008-03-19
Abstract: Information carrier and recording device for recording an information carrier. The information carrier according to the invention is of an optically inscribable type, such as a CD-E or CD-WO. Information can be recorded as a track of patterns on the information carrier. The manufacturer has provided the information carrier with carrier information, for example, information about the write power to be used. It is desirable for the patterns to have constant dimensions, irrespective of the velocity at which they are recorded. The recording process in which for the recording is effected is therefore to be adapted to the recording velocity. In order to attune this adaptation to the information carrier, the latter contains velocity-related information indicative of the recording process related to a recording velocity, for example, a reference velocity (V1-V3), while the remaining recording parameters (W1-W3) are given for a minimum and/or maximum recording velocity at which the information carrier can be recorded. The device reads the velocity-related information from the information carrier and adapts the recording process to the recording velocity that must actually be used.
Patent JP-2968584-B2 (JP)
IPC: H01B17/00
Filed: 1990-10-16
Granted: 1999-10-25
Abstract: PCT No. PCT/GB90/01594 Sec. 371 Date Apr. 15, 1992 Sec. 102(e) Date Apr. 15, 1992 PCT Filed Oct. 16, 1990 PCT Pub. No. WO91/06106 PCT Pub. Date May 2, 1991.A high voltage insulator has a polymeric core that forms a mechanical strength member and an outer covering of a heat-shrinkable polymeric tube that is electrically insulating and non-tracking and that has sheds on its outer surface.
Patent JP-3410092-B2 (JP)
IPC: B65D85/57
Filed: 1993-03-23
Granted: 2003-05-26
Abstract: PCT No. PCT/SE93/00241 Sec. 371 Date Sep. 22, 1994 Sec. 102(e) Date Sep. 22, 1994 PCT Filed Mar. 23, 1993 PCT Pub. No. WO93/19268 PCT Pub. Date Sep. 30, 1993Safety device to be mounted on a parallelepipedic box comprises a frame (10) constructed to encircle the box and having an insert opening (11) for the box and a blocking element (13) displaceably and pivotably mounted to the frame, the blocking element being adjustable between a blocking position and an off position to prevent in the blocking position the box inserted into the frame from being withdrawn from the frame. A spring blade (22) clamped at one end thereof in the blocking element extends in the displacement path of the blocking element to engage at the other, free end thereof behind a shoulder (25) on the frame and thus to prevent displacement of the blocking element in the blocking position, wherein positive engagement is established between the blocking element and the frame in order to prevent the blocking element from pivoting. The spring blade can be actuated by external assembly in order to release the blocking element for adjustment to the off position by displacement or pivotal movement and thus allowing the box to be withdrawn from the frame through the insert opening.
Patent JP-3918041-B2 (JP)
IPC: H01M10/34
Filed: 1995-12-01
Granted: 2007-05-23
Abstract: In the recycling of used nickel/metal hydride storage batteries, the battery scrap is dissolved in sulphuric acid after mechanical separation of the coarse constituents by magnetic and air separation. A solvent extraction is performed with the digestion solution, from which the rare earths (from the hydrogen-storage alloys in the negative electrodes) and iron and aluminum have been selected by precipitation, under conditions pH, choice of solvent, volumetric ratio of the phases) which are such that the aqueous phase contains nickel and cobalt in the same atomic ratio as that in which they were present in the scrap. This makes possible a joint recovery by simultaneous electrolysis, in which process the deposition product forms a master alloy which can be used, together with the precipitated rare earths which have been electrometallurgically reprocessed as misch metal, for the production of fresh hydrogen-storage alloys.
Patent JP-4052665-B2 (JP)
IPC: C07C235/52
Filed: 1995-11-20
Granted: 2008-02-27
Abstract: Novel aryl amides are inhibitors of tumor necrosis factor  alpha  and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is N-benzoyl-3-amino-3-(3',4'-dimethoxyphenyl)propanamide.
Patent JP-4169368-B2 (JP)
IPC: C07D417/14
Filed: 1997-01-14
Granted: 2008-10-22
Abstract: This invention concerns compounds of formula the N-oxide forms, the pharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, wherein X is CH or N; m is 2 or 3 and n is 1, 2 or 3; wherein 1 or 2 C-atoms of the CH2 groups of the moiety which may also contain one double bond, may be substituted with C1-6alkyl, amino, aminocarbonyl, mono- or di(C1-6alkyl)amino, C1-6alkyloxycarbony, C1-6alkylcarbonylamino, hydroxy or C1-6alkyloxy; and/or 2 C-atoms of said CH2 groups may be bridged with C2-4alkanediyl; R1 is hydrogen, C1-6alkyl, C1-6alkyloxy, C1-6alkylthio, amino, mono- or di(C1-6alkyl)amino, Ar, ArNH-, C3-6cycloalkyl, hydroxymethyl or benzyloxymethyl; R2 and R3 are hydrogen, or taken together may form a bivalent radical of formula -CH=CH-CH=CH-; in case X represents CH then L is a radical L1, L2 or L3; or in case X represents N then L is a radical L2 or L3; L1 is Ar-C1-6alkyloxy, Ar-oxy, Ar-thio, Ar-carbonylamino, di-Ar-methyloxy-, N-Ar-piperazinyl, N-Ar-homopiperazinyl, 2-benzimidazolinonyl, Ar-NR4-, Ar-Alk-NR4-, Ar-NR4-Alk-NR5- or Het-NR4-; L2 is Ar, Ar-carbonyl, Ar-CH=CH-CH2-, naphtalenyl or Het; L3 is C1-6alkyl substituted with one or two radicals selected from Ar, Ar-oxy, or Ar-thio, further optionally substituted with cyano or hydroxy; 2,2-dimethyl-1,2,3,4-tetrahydro-naphtalenyl; 2,2-dimethyl-1H-2,3-dihydroindenyl;Ar-piperidinyl or Ar-NR4-Alk-; R4 and R5 are each independently selected from hydrogen or C1-6alkyl; Alk is C1-6alkanediyl; their preparation, compositions containing them and their use as a medicine.
Patent JP-3573754-B2 (JP)
IPC: G01K7/22
Filed: 1997-01-10
Granted: 2004-10-06
Abstract: A structure for temperature sensors and infrared detectors. The structure is built-up on a substrate that includes a thermistor layer, wherein the resistance of the thermistor layer is temperature dependent. The substrate also includes an electric contact layer on both sides of the thermistor layer, and the resistance of the thermistor layer is measured between the contact layers. The thermistor layer includes a monocrystalline quantum well structure that includes alternating quantum well layers and barrier layers. One or more of the bandedge energy of the barrier layers, the quantum well layer doping level, the quantum well layer thickness, and the barrier layer thickness is adapted to obtain a temperature coefficient predetermined for the structure.
Patent JP-3745370-B2 (JP)
IPC: C12P21/02
Filed: 1995-03-30
Granted: 2006-02-15
Abstract: Disclosed and claimed are nucleotides for genes encoding the canine herpesvirus (CHV) gB, gC and gD homologues. These genes encode polypeptides of 879, 459 and 345 amino acids, respectively, which are also disclosed and claimed. The genes are useful as DNA probes or, for preparing PCR primers. The polypeptides are useful in antigenic, immunological or vaccine compositions. The nucleotides can be expressed in any suitable vector system, allowing for production of the polypeptides. Additionally, the vector system containing any or any combination of the nucleotides can be employed in an antigenic, immunological or vaccine composition, such as a poxvirus vector system, e.g., a CHV-vaccinia or avipox virus recombinant, as can the products from expression, i.e., the gB, gC and gD glycoproteins. Antibodies elicited by the glycoproteins or from expression of the vector containing the nucleotide(s) are also useful. Methods for making and using the composition are also disclosed and claimed. Also, specific canarypox-CHV gB, gC and gD recombinants vCP 320, vCP322 and vCP294 and methods for making and using them are also disclosed and claimed.
Patent JP-3476470-B2 (JP)
IPC: D21H21/10
Filed: 1996-04-20
Granted: 2003-12-10
Abstract: PCT No. PCT/EP96/01663 Sec. 371 Date Nov. 3, 1997 Sec. 102(e) Date Nov. 3, 1997 PCT Filed Apr. 20, 1996 PCT Pub. No. WO96/34903 PCT Pub. Date Nov. 7, 1996A graft polymer obtained by free radically polymerizing: (A) a monomer or monomer mixture comprising: (a) from 10-100% by weight of a N-vinylcarboxamide of the formula:  where R1 and R2 are each H or C1-C6-alkyl, (b) from 0-90% by weight of at least one other monoethylenically unsaturated monomer which is copolymerizable with (a), and (c) from 0-5% by weight of at least one monomer having at least two ethylenically unsaturated nonconjugated double bonds in the molecule, in the presence of (B) a polytetrahydrofuran or a polymer which contains at least 3 units of a C2-C4 alkylene oxide and is a hornopolymer of C2-4-alkylene oxide having two free terminal OH groups or random or block copolymers of C2-4-alkylene oxides having two free terminal OH groups or the reaction products of C2-4-alkylene oxides with phenols, amines or fatty carboxylic acids, in a weight ratio (A):(B) ranging from 95:5 to 10:80, some or all of the amide groups having been eliminated by hydrolysis.
Patent JP-3863191-B2 (JP)
IPC: A01G1/00
Filed: 1998-02-18
Granted: 2006-12-27
Abstract: A greening member prepared by fully utilizing a very specific property of bryophytic plants that, even after being separated and dried, the plant body immediately resumes its vital activity in a swollen state when a large amount of water is added thereto and, in addition, the step of drying and the step of wetting can be repeated a large number of times. More specifically, a greening member characterized by comprising a plate preferably comprising a combination of lattice units, one or more holes provided on the surface of the plate, and a plurality of one or more kinds of plant bodies of bryophytic plants mainly belonging to acrocarpous mosses fitted into the hole(s) so that the sides of the plant bodies come into contact with one another or compressed; and a greening member characterized by comprising a bryophytic plant swollen with water in the greening member.
Patent JP-3575768-B2 (JP)
IPC: F24C7/00
Filed: 1997-04-30
Granted: 2004-10-13
Abstract: A flame simulating assembly, such as for an electric heating apparatus, includes a simulated fuel bed (26), a light source (30) and a screen (42) positioned behind the fuel bed (26). The screen (42) has a partially reflecting front surface (44) to provide an image of the fuel bed (26) and a diffusing element behind the partially reflecting surface (44). The diffusing element has a non-planar rear surface.
Patent JP-4187275-B2 (JP)
IPC: C12N5/00
Filed: 1998-04-03
Granted: 2008-11-26
Abstract: The invention relates to a method of harvesting rare cells from a blood product. In one embodiment, the rare cells comprise mononuclear cells and in another embodiment the cells comprise dendritic cells. The method comprises contacting the blood product with a porous medium and selectively retaining the rare cells on the porous medium. The porous medium is contacted with an elution fluid which in one embodiment is a nutrient rich elution fluid and in another embodiment is an elution fluid at a temperature between about 5-37°C. The rare cells are selectively eluted from the porous medium.
Patent ES-2267409-B2 (ES)
Title: Metodo para preparar un acido carboxilico opticamente activo.
Inventor: AMANO AKIRA
IPC: C07C53/128
Filed: 2004-03-26
Granted: 2007-12-16
Abstract: Un método para preparar un ácido carboxílico ópticamente activo deseado con una elevada pureza óptica, en el que el catalizador complejo usado puede ser recuperado y reutilizado como una solución acuosa. El método tiene la etapa de someter un ácido carboxílico Alfa,Beta-insaturado en agua en presencia de un complejo BINAP-Ru sufonado representado por la fórmula [3] [RuX(areno){(SO3 M)2-BINAP ]X [3] en la que X representa un átomo de cloro, un átomo de bromo o un átomo de yodo, areno representa un benceno o un benceno sustituido con alquilo, M representa un átomo de metal alcalino, y BINAP representa 2,3''-bis(difenilfosfina)-1,1''-binaftilo, a una hidrogenación asimétrica. El complejo BINAP sulfonado-Ru puede ser recirculado.
Patent ES-2612581-B2 (ES)
Title: Prelosa aligerada prefabricada y método de fabricación de la misma
Inventor: FRAILE GARCIA ESTEBAN
IPC: E04C2/10
Filed: 2017-01-16
Granted: 2018-01-30
Abstract: La presente invención describe una prelosa aligerada prefabricada que comprende una capa inferior, un elemento aligerante dispuesto sobre la capa inferior que define zonas aligeradas y al menos una zona de nervio, una armadura de refuerzo positivo y una armadura básica electrosoldada en celosía en la al menos una zona de nervio y una capa superior de hormigón por encima del elemento aligerante. El elemento aligerante está compuesto por una estructura de cartón ondulado y poliestireno, definiéndose las zonas aligeradas por bovedillas de cartón ondulado rellenas con tacos de poliestireno y definiéndose la al menos una zona de nervio por una capa doble de cartón ondulado. La presente invención también da a conocer un método de fabricación de la prelosa aligerada de la invención.
Patent AU-2001253692-B2 (AU)
Title: Process and intermediates for making substituted aspartic acid acetals
Inventor: WANNAMAKER MARION W
IPC: C07F9/655
Filed: 2001-04-19
Granted: 2006-11-02
Abstract: Disclosed herein is a method for making compounds that are useful as caspase inhibitor prodrugs of formula I: wherein R<SUP>1 </SUP>is an optionally substituted group selected from an aliphatic group, aralkyl group, heterocyclylalkyl group or aryl group, and R<SUP>2 </SUP>is preferably a P<SUB>2</SUB>-P<SUB>4 </SUB>moiety of a caspase inhibitor. Key intermediates include the azidolactones III and VIII:
Patent AU-2001266338-B2 (AU)
Title: Pharmaceutical compositions for angiogenic therapy
Inventor: AOKI MOTOKUNI
IPC: A61P9/00
Filed: 2001-06-27
Granted: 2006-11-09
Abstract: The present invention provides: (1) pharmaceutical compositions for angiogenic therapy which contain, as the active ingredients, at least one substance selected from substances having vasodilating effect and/or platelet aggregation inhibitory effect, and substances producing them; and a gene encoding an angiogenesis factor; (2) agents for potentiating the angiogenic effect of a gene encoding an angiogenesis factor that contain, as the active ingredient, at least one substance selected from substances having vasodilating effect and/or platelet aggregation inhibitory effect and substances producing them; (3) an angiogenic agent which contains a prostacyclin synthase gene as the active ingredient; (4) pharmaceutical compositions for angiogenic therapy which contain ets-1 gene and another gene encoding an angiogenesis factor as the active ingredients; (4) an agent which contain ets-1 gene as the active ingredient for potentiating the angiogenic effect of another gene encoding an angiogenesis factor; and (5) an angiogenic agent which contains ets-1 gene as the active ingredient.
Patent AU-2001284112-B2 (AU)
Title: Use of GRF1 protein for screening molecules
Inventor: ITIER JEAN-MICHEL
IPC: G01N33/68
Filed: 2001-08-07
Granted: 2007-03-22
Abstract: The invention concerns the use of whole or part of the GRF1 protein, or of cells expressing whole or part of the GRF1 protein, in methods for detecting compounds for preventing and/or treating pathologies or disorders of the central nervous system involving neuronal death, such as apoptosis, or related to leptin metabolism. The pathologies of the central nervous system are in particular cerebral ischemia, Parkinson's disease or Alzheimer's disease.
Patent AU-2002246147-B2 (AU)
Title: Frozen potato product and production method therefor
Inventor: OLMEDO MATIAS ROMERO
IPC: A23L19/12
Filed: 2002-03-20
Granted: 2008-01-24
Abstract: A description is given of a novel frozen potato, similar to fresh potato but with a lower starch content and retaining a lower quantity of oil when fried than par-fried frozen potatoes that exist on the market. To this end, the potatoes undergo a treatment in a saline solution followed later, or in the actual previous stage, by the addition of a food preservative/anti-oxidant, which treatments may optionally be followed by stages of drying with hot air, addition of a color homogenizer, basifying and structure stabilizer for the potato, cooling in a solution with optional addition of food colors and/or flavors, according to the different variant embodiments of the general process that are considered, and all the aforesaid previously undergoing a stage of drying by means of laminar airflow, prior to their freezing. This type of potato may be used in catering in general, being particularly recommended for its low calorie content. <IMAGE>
Patent AU-2002315814-B2 (AU)
Title: Medicinal composition for treatment of interstitial cystitis
Inventor: IKEDA KEN
IPC: A61P13/10
Filed: 2002-07-08
Granted: 2007-05-31
Abstract: Capsaicin-sensory nerve depressant comprises quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate (I) or its salt. An independent claim is also included for agents for treating and preventing interstitial cystitis, hyperesthesia in the lower urinary tract and prostatitis comprising (I) or its salt. ACTIVITY : Antiinflammatory; Uropathic. In tests using Balb/c mice quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate at 1 MicroM significantly (p = 0.043) reduced capsaicin induced plasma extravasation (Evans blue leakage) in the lower urinary tract. MECHANISM OF ACTION : Capsaicin-Antagonist.
Patent AU-2002329526-B2 (AU)
Title: Microfluidic chemical assay apparatus and method
Inventor: MICHEL PHILIPPE
IPC: B01J19/00
Filed: 2002-07-04
Granted: 2007-03-15
Abstract: Apparatus method for performing an electrochemical assay or a reaction, using electrical conductivity and/or power in order either to perform a reduction or an oxidation or an ion transfer reaction, or to perform conductimetry and/or impedance measurements, or to generate an electric field in a solution, or to perform any combination of the aforesaid. The apparatus comprises at least one micro-chip (1) possessing a microstructure (2) (for example a microchannel or array or network of microchannels) having a tip end (3) adapted for uptake of a fluid sample into and/or discharge of a fluid sample from said microstructure, a microfluidic connection end (4) and an integral electrode. It also comprises a microfluidic control unit (11) communicating with the microfluidic connection end of the microstructure and adapted to push, pull or block fluids in the microstructure, and an electrochemical unit adapted to apply an electric field or a current to fluid in the microstructure and/or to measure an electrochemical event therein. Optionally, there is support means adapted to support the micro-chip(s) in relation to the microfluidic control unit in such a manner as to ensure fluid-tight connection therebetween.
Patent AU-2002339260-B2 (AU)
Title: Active pixel sensor
Inventor: HENDERSON PETER CHARLES BOYD
IPC: G06F3/03
Filed: 2002-11-22
Granted: 2005-04-07
Abstract: An active pixel sensor for use in ambient light conditions together with a controlled light source, the sensor producing a difference signal which is indicative of the intensity of light incident on the sensor from the controlled light source. The sensor operates in two phases and includes a photodetector coupled to processing circuitry coupled to storage circuitry. In the first phase, the photodetector generates an ambient light signal and the processing circuitry memorises the ambient light signal. In the second phase the photodetector generates a total light signal, the processing circuitry subtracts the stored memorised ambient light signal from the total light signal to produce the difference signal, and the storage circuitry stores the difference signal. The sensor alternates between the first and second phases in response to receiving a strobing signal, the strobing signal and the controlled light source being synchronised.
Patent AU-2003284428-B2 (AU)
Title: Peptides and medicinal compositions containing the same
Inventor: ENDO KOUSUKE
IPC: A61P13/12
Filed: 2003-11-21
Granted: 2010-08-26
Abstract: This invention provides a pharmaceutical composition comprising, as an active ingredient, a peptide derived from a PACAP or VIP peptide or a pharmaceutically acceptable salt thereof. This invention provides a PACAP/VIP derivative that can inhibit tautomerization in a solution and that can be applied to clinical applications over a long period of time. Such peptides are useful for ameliorating symptoms of diseases, such as regressive neurodegenerative diseases, erectile dysfunction, and bronchial asthma.
Patent AU-2004205779-B2 (AU)
Title: Surface layer affinity-chromatography
Inventor: ROWELL FREDERICK JOHN
IPC: G01N33/558
Filed: 2004-01-20
Granted: 2008-10-16
Abstract: There is described an affinity-chromatography assay system comprising with an immobilized component containing a bio-reagent and a flowable component containing a complimentary bio-reagent characterized in that the immobilized component is supported on a dip strip or planar surface and the flowable component is adapted to flow down the dip strip of high density. There is also described a method of conducting an affinity-chromatography assay which comprises the use of such an assay system.